Meredith M. Miller, PA-C

Meredith Miller practices at Emily F Arsenault MD PA in Bradenton, Florida.

Meredith Miller's NPI, 1518953595, was assigned on September 23, 2005. Meredith Miller holds Florida license PA9101718.

Meredith Miller's primary practice is Emily F Arsenault MD PA, at 230 Manatee E Ave, Bradenton, FL 34208 in Manatee County. The practice phone is (941) 907-0222.

Meredith Miller's primary practice is Emily F Arsenault MD PA in Bradenton, Florida. The medical group on file is Arsenault Dermatology. Dmand AI also links Meredith Miller to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Meredith Miller practices. Vendor and product names are available with a free account.

Medical is Meredith Miller's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Meredith Miller is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Meredith Miller is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and itchy rashes among the conditions Meredith Miller treats.

CMS data shows 1,295 Medicare services from Meredith Miller across 11 procedure codes in 2024, for 376 Medicare patients. Medicare paid $37,986 for them. Every service was in an office.

CMS counts 376 Medicare patients who saw Meredith Miller in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Meredith Miller's median patient age at 65, with 25% women.

In 2024, Meredith Miller wrote 462 Medicare Part D claims for 240 patients. 97% of them were for generic drugs. CMS names the drug for 335 of them, across 13 drugs with 11 or more claims each, at $6,572 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Meredith Miller for performance year 2024, reported individually. Meredith Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Meredith Miller from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $121.